Autoimmune neutropenia

La Revue de médecine interne
J MartinM Hamidou

Abstract

Autoimmune neutropenias (AIN) are classically divided into primary AIN and secondary AIN. The latter are associated with autoimmune disorders, hematologic malignancies, primary immune deficiencies, drug exposure or infections. In this review we will focus on the major aetiologies of AIN, their differential diagnosis, the various methods in biological diagnosis, and the treatment.

References

Aug 1, 1977·British Journal of Haematology·F W VerheugtC P Engelfriet
Apr 1, 1975·Journal of Immunological Methods·A F Jiang, P Lalezari
May 1, 1997·British Journal of Haematology·S B KillickE C Gordon-Smith
Aug 1, 1997·International Journal of Epidemiology·D S FreedmanT Byers
Apr 17, 2001·Current Opinion in Hematology·M A Smith, J G Smith
Mar 15, 2002·Current Allergy and Asthma Reports·R L Fuleihan
Jun 18, 2002·Clinical and Laboratory Haematology·V GuptaM J Mills
Sep 30, 2004·Best Practice & Research. Clinical Rheumatology·Geza P Balint, Peter V Balint
Nov 25, 2004·Hematology·Nancy BerlinerThomas P Loughran
Feb 18, 2006·Rheumatology·D Martínez-BañosJ Sánchez-Guerrero
Mar 15, 2006·Blood Reviews·Eric J Burks, Thomas P Loughran
Apr 14, 2006·British Journal of Haematology·Austen WorthH Bobby Gaspar
Apr 7, 2007·Autoimmunity Reviews·Philipp von LandenbergSusanne Modrow
May 2, 2007·Annals of Internal Medicine·Frank AndersohnEdeltraut Garbe
Oct 6, 2007·The British Journal of Dermatology·R Rios-FernándezN Ortego-Centeno
Oct 6, 2007·Immunologic Research·Hans D OchsTroy R Torgerson
Oct 6, 2007·Current Opinion in Rheumatology·Georg BohnChristoph Klein
Nov 29, 2007·Current Opinion in Hematology·Jan Palmblad, Helen A Papadaki
Nov 29, 2007·Current Opinion in Hematology·Emmanuel Andrès, Frédéric Maloisel
Jan 23, 2008·Vox Sanguinis·J Bux
Apr 2, 2008·Seminars in Arthritis and Rheumatism·Pilar Brito-ZerónManuel Ramos-Casals
May 14, 2008·Annals of the Rheumatic Diseases·H MarotteP Miossec
Nov 26, 2008·Autoimmunity Reviews·Guillaume Bussone, Luc Mouthon
Dec 6, 2008·Current Opinion in Hematology·Toshinao Kawai, Harry L Malech
Mar 19, 2009·Autoimmunity Reviews·Mojtaba AkhtariEdmund K Waller

❮ Previous
Next ❯

Citations

Aug 10, 2013·La Revue de médecine interne·E LazaroJ-F Viallard
Jun 23, 2015·La Revue de médecine interne·S NgoH Lévesque
Apr 2, 2019·Computer Methods in Biomechanics and Biomedical Engineering·Marcelo Bighetti ToniolloAndrea Sayuri Silveira Dias Terada
Oct 31, 2017·Biomedit︠s︡inskai︠a︡ khimii︠a︡·K Yu TsukanovV V Ilinsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.